Adaptive Biotechnologies Corp financial data

Symbol
ADPT on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
1165 Eastlake Ave E, Seattle, WA
State of incorporation
Washington
Fiscal year end
December 31
Former names
Adaptive TCR Corp (to 6/2/2011)
Latest financial report
10-Q - Q2 2024 - Aug 1, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 446 % -15.4%
Quick Ratio 17.2 % -3.05%
Debt-to-equity 118 % +36.9%
Return On Equity -72 % -67%
Return On Assets -33 % -42.7%
Operating Margin -129 % -29.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 147M shares +1.95%
Common Stock, Shares, Outstanding 147M shares +1.95%
Entity Public Float 756M USD -15.9%
Common Stock, Value, Issued 14K USD 0%
Weighted Average Number of Shares Outstanding, Basic 147M shares +2.09%
Weighted Average Number of Shares Outstanding, Diluted 147M shares +2.09%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 169M USD -11%
Research and Development Expense 113M USD -14.3%
Selling and Marketing Expense 85M USD -6.98%
General and Administrative Expense 78.3M USD -9.3%
Costs and Expenses 387M USD +2.02%
Operating Income (Loss) -218M USD -15%
Net Income (Loss) Attributable to Parent -213M USD -11.8%
Earnings Per Share, Basic -1.47 USD/shares -11.4%
Earnings Per Share, Diluted -1.47 USD/shares -11.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 59.8M USD -45.2%
Accounts Receivable, after Allowance for Credit Loss, Current 35.6M USD +12.9%
Inventory, Net 13.2M USD -30.3%
Assets, Current 352M USD -26.3%
Property, Plant and Equipment, Net 55.4M USD -30.2%
Operating Lease, Right-of-Use Asset 48.5M USD -37.1%
Goodwill 119M USD 0%
Other Assets, Noncurrent 3.15M USD -5.97%
Assets 585M USD -23.5%
Accounts Payable, Current 9.87M USD +7.68%
Employee-related Liabilities, Current 9.52M USD -9.81%
Accrued Liabilities, Current 6.71M USD -19.7%
Contract with Customer, Liability, Current 52.2M USD -9.83%
Liabilities, Current 88.1M USD -7.56%
Contract with Customer, Liability, Noncurrent 38.8M USD -23.7%
Operating Lease, Liability, Noncurrent 84.4M USD -10.4%
Other Liabilities, Noncurrent 20K USD
Liabilities 343M USD -6.82%
Accumulated Other Comprehensive Income (Loss), Net of Tax -182K USD +79.6%
Retained Earnings (Accumulated Deficit) -1.24B USD -20.8%
Stockholders' Equity Attributable to Parent 242M USD -39%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 241M USD -39%
Liabilities and Equity 585M USD -23.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -38.4M USD +35.2%
Net Cash Provided by (Used in) Financing Activities 44K USD -93.5%
Net Cash Provided by (Used in) Investing Activities 44.5M USD -29.3%
Common Stock, Shares Authorized 340M shares 0%
Common Stock, Shares, Issued 147M shares +1.95%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6.2M USD +37.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.29M USD -17.1%
Deferred Tax Assets, Valuation Allowance 402M USD +16.1%
Deferred Tax Assets, Gross 417M USD +12.2%
Operating Lease, Liability 94.2M USD -9.03%
Depreciation 4.79M USD -4.26%
Payments to Acquire Property, Plant, and Equipment 1.51M USD -48.3%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -213M USD -14.4%
Lessee, Operating Lease, Liability, to be Paid 115M USD -10.8%
Property, Plant and Equipment, Gross 141M USD +2.66%
Operating Lease, Liability, Current 9.81M USD +4.93%
Lessee, Operating Lease, Liability, to be Paid, Year Two 12.3M USD -12.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 14.1M USD +2.97%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 20.3M USD -18.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 11.9M USD -3.13%
Deferred Tax Assets, Operating Loss Carryforwards 252M USD +19.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 9.3M USD +14.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four 12.3M USD +2.83%
Operating Lease, Payments 3.7M USD +8.82%
Additional Paid in Capital 1.48B USD +4.1%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 1.7M USD +0.29%
Deferred Tax Assets, Net of Valuation Allowance 14.5M USD -41.9%
Share-based Payment Arrangement, Expense 58.1M USD -3.81%
Interest Expense 12.4M USD -25.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%